| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.064 | 0.03 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.04 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.04 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.068 | 0.04 |